Glycemic Monitoring and Management in Advanced Chronic Kidney Disease
WEBMay 26, 2020 · CKD stages are based on estimated glomerular filtration ratios as follows: stage I: less than 90, stage II: 60 to 89, stage III: less than 60, stage IV: less than 30, stage V: less than 15 mL/min/1.73 m 2).
Continuous glucose monitoring in people with diabetes and end-stage …
WEBNov 21, 2023 · Over the past decade, the field of continuous glucose monitoring has been greatly improved and expanded. This review examines the use of continuous glucose monitoring in people with end-stage kidney disease treated with hemodialysis (HD), peritoneal dialysis (PD), or kidney transplantation.
Assessment of Glycemic Control by Continuous Glucose Monitoring …
WEBDec 12, 2023 · Patients with diabetes and end-stage kidney disease (ESKD) may experience “burnt-out diabetes,” defined as having an HbA 1c value <6.5% without antidiabetic therapy for >6 months. We aim to assess glycemic control by continuous glucose monitoring (Dexcom G6 CGM) metrics and glycemic markers in ESKD patients on hemodialysis with burnt-out ...
Consensus Statement on Inpatient Use of Continuous Glucose Monitoring
WEBApr 21, 2017 · Information obtained from CGM includes glucose concentration, trajectory of glucose change (increasing, decreasing, or stable) and rate of glucose change (slow, fast, or steady). These data is used to facilitate short and long-term therapy adjustments and limit glycemic excursions.
Measurements of chronic glycemia in diabetes mellitus
WEBAug 12, 2024 · Measures of chronic glycemia (eg, glycated hemoglobin or CGM-derived mean glucose, time-in-range, and glucose management indicator [GMI]) are used to determine the overall efficacy of diabetes management with the aim of reducing risk for long-term complications.
Continuous glucose monitoring in people with diabetes and end-stage …
WEBNov 21, 2023 · This review examines the use of continuous glucose monitoring in people with end-stage kidney disease treated with hemodialysis (HD), peritoneal dialysis (PD), or kidney transplantation.
WEBOverall, the use of continuous glucose monitoring in individuals with end-stage kidney disease may improve glycemic control and detection of hypoglycemia. However, most of the published studies were observational with no control group. Moreover, not all studies used the same assessment parameters.
Continuous glucose monitoring in patients with type 2 …
WEBMar 20, 2021 · We undertook a literature review searching for multiple pairs of keywords, including “continuous glucose monitoring and hemodialysis,” “continuous glucose monitoring and end-stage renal disease,” and “continuous glucose …
Comment on Kaminski et al. Assessment of Glycemic Control by Continuous …
WEBJul 25, 2024 · The pilot study by Kaminski et al. (1) that was recently published in Diabetes Care assessed glycemia in patients with end-stage kidney disease (ESKD) with “burnt-out diabetes” by measuring interstitial fluid glucose with a …
Continuous glucose monitoring in an end-stage renal disease …
WEBHere, we report a 48-year-old male with ESRD due to diabetes receiving thrice-weekly hemodialysis who experienced decreased patient-burden, greater glucose monitoring adherence, improved glycemic parameters, and reduction in hypoglycemia after transitioning to CGM.